A randomized trial of a drug commonly used to treat gout that reduces inflammation found that the medication did not help people with long covid. This medication targets inflammation in a different ...

The German government has committed half a billion euros for research on long COVID and other post-infection syndromes.

It's difficult to predict the prevalence of a condition when you don't know what it is, and it's even more difficult to diagnose and treat it. But that's essentially what's happening with long COVID, ...

Long COVID still affects people worldwide with stubborn symptoms like fatigue and cognitive issues. A clinical trial tested ...

Ziyad Al-Aly is chief of research and development at VA St. Louis Health Care System and a clinical epidemiologist at Washington University in St. Louis. Since 2020, the condition known as long ...

Research from Thailand shows high long COVID prevalence in hospitalized patients, with severe illness increasing risk and ...

UC San Francisco scientists have found that SARS-CoV-2 can linger in the body for years and could be driving a global epidemic in long COVID. They’re also exploring the surprising long-term risks of ...

Five years after the start of the pandemic, a group of researchers from Beth Israel Deaconess Medical Center is one step ...

Five years after she took the First COVID-19 shot in the US, Sandra Lindsay reflects on hope and how it's challenging to ...

A newer COVID variant called XFG is currently fueling cases of the virus across the country. Nicknamed “ Stratus,” this ...